A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO)

BACKGROUND: Clostridium difficile is the most common cause of hospital-acquired infections, responsible for >450000 infections annually in the USA. Probiotics provide a promising, well-tolerated adjunct therapy to standard C. difficile infection (CDI) treatment regimens, but there is a paucity of...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Antimicrob Chemother
मुख्य लेखकों: Barker, Anna K, Duster, Megan, Valentine, Susan, Hess, Timothy, Archbald-Pannone, Laurie, Guerrant, Richard, Safdar, Nasia
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Oxford University Press 2017
विषय:
Original Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5890711/
https://ncbi.nlm.nih.gov/pubmed/28961980
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkx254
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन